Human Epilepsy Genetics--Neuronal Migration Disorders Study
1 other identifier
observational
3,500
1 country
1
Brief Summary
The purpose of this study is to identify genes responsible for epilepsy, brain malformations and disorders of human cognition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 1996
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 1996
CompletedFirst Submitted
Initial submission to the registry
July 11, 2002
CompletedFirst Posted
Study publicly available on registry
July 12, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2030
September 21, 2023
September 1, 2023
34.2 years
July 11, 2002
September 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identification and characterization of genes important in normal brain development and associated with brain malformations.
Genetic variants associated with disorder of brain development
Ongoing
Eligibility Criteria
Participants will be selected through collaborations with clinicians.
You may qualify if:
- Males and females of any age.
- Persons with a brain malformation or disorder of cognition (familial intellectual disability \[previously known as mental retardation\] or autism).
You may not qualify if:
- Persons without a brain malformation or disorder of cognition (familial intellectual disability (previously known as mental retardation\] or autism).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Children's Hospital, Walsh Laboratory
Boston, Massachusetts, 02115, United States
Related Links
Biospecimen
whole blood, DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher A. Walsh, M.D., Ph.D.
Harvard Institutes of Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
July 11, 2002
First Posted
July 12, 2002
Study Start
April 1, 1996
Primary Completion (Estimated)
June 1, 2030
Study Completion (Estimated)
June 1, 2030
Last Updated
September 21, 2023
Record last verified: 2023-09